Commonwealth Equity Services
VERA icon

Commonwealth Equity Services’s Vera Therapeutics VERA Stock Holding History

Commonwealth Equity Services’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,256
Closed -$252K – 4570
2026
Q1 		$252K Buy
6,256
+115
+2% +$4.96K ﹤0.01% 3785
2025
Q4 		$311K Buy
+6,141
New +$218K ﹤0.01% 3621

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Commonwealth Equity Services's VERA Position: Q2 2026 in Review

Commonwealth Equity Services sold out of Vera Therapeutics (VERA) in Q2 2026, closing a stake of 6,256 shares — an estimated $252K sold.

Commonwealth Equity Services first reported a position in VERA in Q4 2025 and held it in 2 quarters. The position peaked at $311K in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Commonwealth Equity Services reported no remaining Vera Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Commonwealth Equity Services sold 6,256 Vera Therapeutics shares in Q2 2026, an estimated $252K.
  • Commonwealth Equity Services first reported a position in Vera Therapeutics in Q4 2025 and held it in 2 quarters.
  • Commonwealth Equity Services's Vera Therapeutics position peaked at $311K in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.